# Vascular Lifestyle-Intervention and Screening in Pharmacy

> **NCT02223793** · NA · UNKNOWN · sponsor: **University of Oslo** · enrollment: 582 (actual)

## Conditions studied

- Cardiovascular Diseases
- Hypercholesterolemia
- Dyslipidemia
- Hypertensive Disease
- Diabetes Mellitus, Type 2

## Interventions

- **BEHAVIORAL:** Information on high risk factor levels and lifestyle advice
- **BEHAVIORAL:** No information on high risk factor levels but lifestyle advice
- **BEHAVIORAL:** No information on high risk factor levels, nor lifestyle advice

## Key facts

- **NCT ID:** NCT02223793
- **Lead sponsor:** University of Oslo
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-09
- **Primary completion:** 2015-12
- **Final completion:** 2022-02
- **Target enrollment:** 582 (ACTUAL)
- **Last updated:** 2020-05-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02223793

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02223793, "Vascular Lifestyle-Intervention and Screening in Pharmacy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02223793. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*